| Structure |
Chemical Name |
CAS |
MF |
![2-hydroxy-3-oxobutyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate](/) |
2-hydroxy-3-oxobutyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
|
|
 |
5-Decyano 5-(Ethyl Formate) Milrinone |
80442-07-5 |
C14H14N2O3 |
![2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5- (difluoromethoxy)-1Na-benzo[d]imidazole](/) |
2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5- (difluoromethoxy)-1Na-benzo[d]imidazole |
|
|
 |
Doxofylline Impurity 11 |
109403-76-1 |
C15H16N8O4 |
 |
ethyl (S)-6,7,8-trifluoro-1-(1-hydroxypropan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate |
110548-03-3 |
C15H14F3NO4 |
 |
Ozagrel Impurity 1 |
|
|
 |
Meropenem impurity diastereomer 2 |
96035-15-3 |
C15H19N3O5S |
 |
Aprepitant |
1242175-38-7 |
C20H18F7NO2 |
 |
Clindamycin Impurity F |
|
|
![1,4-di(benzo[b]thiophen-4-yl)piperazine](/CAS/20180703/GIF/1420987-86-5.gif) |
1,4-di(benzo[b]thiophen-4-yl)piperazine |
1420987-86-5 |
C20H18N2S2 |
 |
Donepezil Impurity |
896134-06-8 |
C17H15NO4 |
 |
trans-Ibuprofen Impurity G |
|
C13H18O2 |
 |
Lamivudine Impurity 4 |
|
|
 |
Trelagliptin Impurity 42 |
|
|
![N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine](/CAS/20180629/GIF/1052691-22-1.gif) |
N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine |
1052691-22-1 |
C10H19N3S |
 |
Varenicline Impurity 5 |
950781-87-0 |
C11H13N3O2 |
 |
Palbociclib impurity LMAP |
|
|
 |
Butyphthalide impurity 35 |
|
|
 |
EsCitalopram EP Impurity I |
1370643-22-3 |
C20H21FN2O |
 |
カフェイジン酸 |
54536-15-1 |
C8H12N4O3 |
 |
(1-carboxy-1-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)ethyl)-L-cysteine |
|
|
 |
Lucidin 3-O-glucoside |
22255-29-4 |
C21H20O10 |
 |
Itraconazole iMpurity 5 |
|
|
 |
Empagliflozin Impurity 23 |
|
|
 |
溶剤脱ワックス重質飽和炭化水素石油蒸留物 |
64742-65-0 |
|
 |
Fesoterodine Related Impurity 2 |
1254942-29-4 |
C30H39NO6 |
 |
2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine |
1353100-18-1 |
C13H18ClNO |
 |
Dapoxetine Impurity 11 |
151649-29-5 |
C19H16O |
 |
1175018-73-1 |
1175018-73-1 |
C12H14ClN |
 |
Canagliflozin Impurity 998 |
|
|
 |
Oseltamivir Impurity 108 |
|
|
 |
Doxofylline Impurity 5 |
|
|
 |
(2-(methyl((vinyloxy)carbonyl)amino)pyridin-3-yl)methyl 2-(methylamino)acetate hydrochloride |
|
|
 |
3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル |
20850-49-1 |
C13H17NO2 |
 |
Tazobactam Impurity LTE |
|
|
 |
Tofacitinib Impurity 87 |
|
|
 |
Perindopril IMpurity E |
|
|
 |
Azilsartan iMpurity |
1604812-35-2 |
C35H28N4O11 |
 |
Fondaparinux sodium impurity 12 |
|
|
 |
cefoxitin iMpurity B |
|
|
 |
D,L N-Desmethylvenlafaxine |
149289-30-5 |
C16H25NO2 |
 |
Ropivacaine-iPr |
175888-75-2 |
C17H26N2O |
 |
Furosemide Impurity 2 |
|
C12H11ClN2O5S |
 |
Tirofiban Impurity 3 |
1346918-32-8 |
C13H19NO5S |
 |
Oseltamivir Diastereomer III HCl |
2413185-95-0 |
C16H28N2O4 |
 |
1-(2,5-ジフルオロフェニル)-2-(1H-1,2,4-トリアゾール-1-イル)エタノン |
1157938-97-0 |
C10H7F2N3O |
 |
Cephalexin Impurity 2 |
|
C16H17N3O4S |
 |
Linagliptin Impurity D |
666816-91-7 |
C20H28N6O4 |
 |
5,9,13,17-Nonadecatetraen-2-one, 6,10,14,18-tetramethyl-, (Z,E,Z)- (8CI) |
3879-25-2 |
C23H38O |
 |
Dextrorotation lansoprazole Impurity M |
|
|
 |
Tazobactam Impurity 4 |
|
|
 |
5-(Propylthio)-1H-benzimidazol-2-amine |
80983-36-4 |
C10H13N3S |
 |
Brexpiprazole Impurity ABCDEFGHJKL |
|
|
 |
Solifenacin Related CoMpound 5 |
|
|
 |
Afatinib impurity 49 |
|
|
 |
Tofacitinib Impurity 110 |
|
|
 |
Ozagrel Impurity 2 |
|
|
 |
(3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride |
|
C14H24Cl2N2 |
 |
Empagliflozin Impurity 62 |
1620758-30-6 |
C23H27ClO8 |
 |
Ninhydrine, ozone friendly ready to use spray for TLC chromatography |
32-70-2 |
C9H4O3.H2O
|
![1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-](/CAS/20210305/GIF/1642569-42-3.gif) |
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- |
1642569-42-3 |
C20H17N5O5 |
 |
Carfilzomib Impurity 5 |
|
|
 |
Moxifloxacin Impurity 14 |
|
|
 |
6-(3-CHLOROPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE |
4514-54-9 |
C9H8ClN5 |
 |
Pralatrexate Impurity 13 |
|
|
 |
Axitinib Sulfonyl |
1348536-59-3 |
C22H18N4O3S |
 |
Helium-Argon mixture |
|
|
 |
Rosuvastatin Impurity 131 |
|
|
 |
ペリンドプリラットラクタムB |
130061-28-8 |
C17H26N2O4 |
 |
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine |
641571-16-6 |
C11H10F3N3 |
 |
ethyl 7-chloro-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate |
75073-15-3 |
C12H9ClFNO3 |
 |
Cefazolin Impurity EP-E |
|
|
 |
cefaclor iMpurity G |
67308-21-8 |
C16H17N3O4S |
![6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one](/CAS/GIF/571189-64-5.gif) |
6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
571189-64-5 |
C15H18N4O2 |
 |
Clindamycin 2,4-Diphosphate |
1309048-48-3 |
C18H35ClN2O11P2S |
 |
Tamoxifen EP Impurity H |
809285-09-4 |
C43H48N2O2 |
 |
Adefovir Impurity 1 |
|
|
 |
5-ニトロ-2-フランカルボアルデヒド(5-ニトロ-2-フラニル)メチレンヒドラゾン |
736-53-8 |
C10H6N4O6 |
 |
N-(Ethylamino) Fluvoxamine
|
1217262-11-7 |
C17H26F3N3O2 |
 |
Dapoxetine Impurity B |
|
|
 |
Rocuronium Bromide Impurity 28 、29 |
|
|
 |
Roxadustat Impurity 16 |
|
|
 |
3-(3-TRIFLUOROMETHYL-PHENYL)-PROPYLAMINE |
104774-87-0 |
C10H12F3N |
 |
(E)-4-アミノクロトン酸 |
38090-53-8 |
C4H7NO2 |
 |
Terlipressin Impurity 1 (des-Gly1) |
|
|
 |
Carbazochrome Sodium Sulfonate Impurity I |
|
|
 |
3-アミノ-2-ブテン酸 |
21112-45-8 |
C4H7NO2 |
 |
Flucloxacillin impurity C |
|
|
 |
2-(2-Ethoxyphenoxy)ethyl Methanesulfonate |
169506-15-4 |
C11H16O5S |
 |
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
 |
2-Hydroxy Cephalexin |
215172-75-1 |
C16H17N3O5S |
 |
ブロバクタムS,S-ジオキシド |
75527-87-6 |
C8H10BrNO5S |
 |
Everolimus Impurity E |
|
|
 |
Bendamustine Impurity 37A |
|
|
 |
IMp. E (EP): 4-AMino-5-(ethylsulphonyl)-2-Methoxybenzoic Acid |
|
|
 |
Tofacitinib Impurity L |
|
|
 |
1-(1-BENZOTHIOPHEN-7-YL)PIPERAZINE |
105685-06-1 |
C12H14N2S |
 |
3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)- |
1025974-23-5 |
C11H14O4S |
 |
Bisoprolol-d5 |
1189881-87-5 |
C18H31NO4 |
![1H-Pyrrole-3-methanamine, 1-[(1,4-dihydro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-N-methyl-](/CAS/20200611/GIF/2416241-98-8.gif) |
1H-Pyrrole-3-methanamine, 1-[(1,4-dihydro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-N-methyl- |
2416241-98-8 |
C17H18FN3O2S |